Anbio biotech (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Anbio Biotechnology - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Anbio Biotechnology - Ordinary Shares - Class A
Rating: 1.33866675
Author: Trendlyne DVM scores

about

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medic...

29.48 -0.59 (-1.96%)

47.03% Fall from 52W High

22,304

XNAS Volume

XNAS 02 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Anbio biotech (Class A) is on 06 Jan 2026 for the purpose of Anbio Biotechnology Third Quarter Earnings Results for 2025 See details